In recent years, scientists have developed drugs can help shrink cancerous tumors. Several of these target P13K, an enzyme involved in cellular growth that is known to contribute to causing cancers.

But the anti-cancer drugs that target P13K don’t work as well as scientists had hoped. The problem is that the drugs also cause a spike in insulin, which helps tumors grow. The spike could compromise the effectiveness of the cancer therapies.

One solution is to supplement a patient’s cance